PDL BioPharma, Inc. today announced the election of David Parkinson, M.D., as a member of the board of directors of Facet Biotech Corporation, the biotechnology company PDL plans to spin off into a separate, publicly-held company, effective on or about December 18, 2008. Go to source

A strong pipeline makes the Copenhagen Region biotech cluster well prepared for the challenges ahead. With 185 drug candidates in preclinical and clinical development, Denmark ranks third in Europe. Go to source

There are seven Member States (MS) commercially producing genetically-engineered (GE) crops, with Spain being, by far, the largest producer. Under the EU policy framework for agricultural biotechnology, MS policy varies greatly. Go to source

Another key regulatory milestone has been achieved as one of the most anticipated U.S. soybean technologies approaches commercialization. Monsanto Company announced today it has received regulatory approval in the European Union for the importation of Roundup Ready 2 Yield™ soybeans. Go to source

The UK’s struggling biotechnology sector has added itself to the growing queue of industries seeking state support. A group of leading industry figures has warned of a collapse unless the government comes up with £500m to match private investors’ funds to trigger consolidation. Go to source

Organisation: IAEA - International Atomic Energy Agency
Summary: The Analytical Chemist is a technical specialist, an innovator of analytical techniques and methods, a supervisor of staff carrying out complex operations in the field of sample processing, and a planner of the use of staff and equipment, the procurement of new laboratory equipment and the introduction of new analytical procedures.

Go to source

Organisation: HPA - Health Protection Agency
Summary: This is an exciting opportunity to join one of the largest microbiology departments in United Kingdom. HPA is looking for the right individual to take on this permanent post, performing serological evaluation of meningococcal vaccines. Immunoassays include ELISA, bioassays and flow analysis.

Go to source

Organisation: F. Hoffmann-La Roche Ltd
Summary: The successful candidate will support the selection and timely development of potential new medicines through close interactions with discovery therapeutic areas, and affiliated non-clinical and clinical development functions.

Go to source

Organisation: University of Paris-Sud
Summary: Interactions and Dynamics of Surface Geology (IDES) is a laboratory from the National Centre of Scientific Research (CNRS) and University of Paris-Sud 11. IDES is looking for a Ph.D. student to study the microstructures and molecular processes involved in the biomineralization of commercially-important bivalve larvae. These techniques will be employed to understand how future changes in the climate of coastal waters, caused by predicted increases in temperature and CO2, will affect the growth and development of shellfish larvae.

Go to source

Organisation: Centre de Regulació Genòmica (CRG)
Summary: The objective of the CRG is to promote excellent basic research in biomedicine and, particularly, in the genomic and proteomic fields.

Go to source